Kevin W. Quinlan
Chief Financial Officer

Gregory T. Fulton
Chief Commercial Officer

William J. Mrachek
Vice President, Human Resources

Randall W. Wilhoite
Vice President, Operations

Irina B. Kulinets
Vice President, Regulatory and Clinical Affairs

Andrew J. Carter. Ph.D.
Chief Technology Officer

Kevin W. Quinlan
Chief Financial Officer
Prior to joining Anika in 2005, Mr. Quinlan was President, BBI Diagnostics, a division of SeraCare, which was acquired in 2004 from Boston Biomedica, Inc ("BBI"). From 1999 to 2004, he served as President and Chief Operating Officer of BBI, then a publically traded manufacturer of quality control products used to monitor infectious disease testing, and had operational and P&L responsibility for BBI's five business units. Mr. Quinlan previously served as Chief Financial Officer of BBI from 1993 to 2003. As CFO, he was responsible for finance, IT, treasury, human resources and investor relations. From 1990 to 1993, Mr. Quinlan was CFO of Parctec, Inc (a subsidiary of Kleinwort Benson Group). Between 1981 to 1990, Mr. Quinlan was Vice President, Assistant Treasurer and Corporate Controller of American Finance Group. From 1975 to 1981, Mr. Quinlan was an auditor/senior auditor/audit supervisor at Coopers & Lybrand. Mr. Quinlan is a Certified Public Accountant and has degrees from both the University of New Hampshire and Northeastern University.
back to top

Gregory T. Fulton
Chief Commercial Officer
Prior to joining Anika in 2007, Mr. Fulton served as Vice President, U.S. Marketing, for Genzyme Biosurgery, a division of Genzyme Corporation. Mr. Fulton began his career at Eli Lilly and Company in 1981. He has spent over 25 years in the pharmaceutical/biotech industry in positions of increasing responsibility within commercial operations, specifically in the areas of sales, brand management, marketing research, business development and new product development. During the course of his career, Mr. Fulton has worked with several leading U.S. and international companies, including Lederle Laboratories, a division of American Cyanamid, Ortho-McNeil Pharmaceuticals, a division of Johnson & Johnson, Boehringer Ingelheim Pharmaceuticals, Bayer Pharmaceuticals and Reliant Pharmaceuticals. Mr. Fulton brings significant knowledge of product launches, partnership management, strategic planning and building commercial organizations. He holds a bachelor's degree in marketing management from Virginia Polytechnic Institute and State University, and an M.B.A. from the Colgate Darden Graduate School of Business Administration at the University of Virginia.
back to top

William J. Mrachek
Vice President, Human Resources
Mr. Mrachek joined Anika in 2001 and in 2003 became the Executive Director of Human Resources. Previously, he served as the Vice President of Human Resources for iQ NetSolutions, a start-up engaged in the proprietary Enterprise telephony solutions converging both voice and data. From 1994 to 2000, Mr. Mrachek was Director of Human Resources for Programart Corp in Cambridge, MA, a private software company developing application performance management products for the mainframe market. Previously, Mr. Mrachek served as Vice President of Human Resources for SofTech, Inc., a public company located in Waltham, MA, engaged in selling software development and engineering services primarily for the Federal government as well as the product reselling of computers, network equipment, and packaged software. Mr. Mrachek holds his Bachelor of Arts degree from Colorado College, his MBA from the University of Denver, and his JD from the University of Colorado School of Law. He serves on the Board of Directors for the Faulkner Hospital in Boston.
back to top

Randall W. Wilhoite
Vice President, Operations
Randall Wilhoite is Vice President of Operations at Anika Therapeutics. He joined the Company in January 2006 as Director of Planning & Logistics and in January 2007 became Director of Operations. Prior to joining Anika, Mr. Wilhoite was a supply chain manager for Oscient Pharmaceuticals, a biopharmaceutical company that develops therapeutics to address unmet medical needs. From 1988 to 2004, he held various management positions at Abbott Laboratories with increasing responsibilities in operations, planning and distribution. He holds a bachelor's degree in chemistry from the University of Indiana.
back to top

Irina B. Kulinets
Vice President, Regulatory and Clinical Affairs
Irina Kulinets is the Vice President of Regulatory and Clinical Affairs at Anika Therapeutics. She joined the company in 2007 previously serving as Senior Director of Regulatory Affairs at BioSphere Medical in Rockland, MA. She has 17 years of experience in the medical device industry with large and small manufacturers including Boston Scientific, Johnson & Johnson/DePuy, and OmniGuide where she served in various Regulatory Affairs, Clinical Affairs, and Quality Assurance technical, management and senior management roles. From 2001 to 2004 she served as a Medical Regulatory Reviewer and Lead Medical Auditor for Notified Body, TUV America. In addition, she is certified by the FDA as a Third Party 510K reviewer. She holds MS and BS degrees in Mechanical Engineering from Belarus Polytechnic Academy and MS in Quality Assurance from California State University, Dominguez Hills. She is RAPS certified RAC, ASQ certified Six Sigma Black Belt, and ASQ Certified Quality Engineer.
back to top

Andrew J. Carter, Ph.D.
Chief Technology Officer
Prior to joining Anika, Dr. Carter was vice president and general manager at Spine Wave, Inc., in Shelton, CT, a private company focused on developing innovative medical devices for the treatment of spinal disorders. Prior to Spine Wave, Inc., from 1982 to 2003, he held a variety of positions with increasing responsibilities with Smith & Nephew both in the United Kingdom, and with S&N Endoscopy in Massachusetts. His research and product development responsibilities within Smith & Nephew included materials research, consumer products, wound management, orthopedics, arthroscopy and tissue engineering. Dr. Carter holds his degrees from Queen Mary College, the University of London, with a Ph.D. and a B.Sc. both in Polymer Science and Technology.
back to top